全文获取类型
收费全文 | 23785篇 |
免费 | 3041篇 |
国内免费 | 1211篇 |
专业分类
耳鼻咽喉 | 67篇 |
儿科学 | 268篇 |
妇产科学 | 121篇 |
基础医学 | 3216篇 |
口腔科学 | 378篇 |
临床医学 | 1658篇 |
内科学 | 3357篇 |
皮肤病学 | 232篇 |
神经病学 | 991篇 |
特种医学 | 441篇 |
外国民族医学 | 6篇 |
外科学 | 1400篇 |
综合类 | 3985篇 |
现状与发展 | 8篇 |
预防医学 | 1857篇 |
眼科学 | 303篇 |
药学 | 4807篇 |
12篇 | |
中国医学 | 3041篇 |
肿瘤学 | 1889篇 |
出版年
2024年 | 97篇 |
2023年 | 689篇 |
2022年 | 981篇 |
2021年 | 1517篇 |
2020年 | 1373篇 |
2019年 | 1126篇 |
2018年 | 969篇 |
2017年 | 1027篇 |
2016年 | 1090篇 |
2015年 | 1151篇 |
2014年 | 1646篇 |
2013年 | 1934篇 |
2012年 | 1615篇 |
2011年 | 1587篇 |
2010年 | 1236篇 |
2009年 | 1100篇 |
2008年 | 1104篇 |
2007年 | 1067篇 |
2006年 | 864篇 |
2005年 | 841篇 |
2004年 | 669篇 |
2003年 | 656篇 |
2002年 | 546篇 |
2001年 | 432篇 |
2000年 | 358篇 |
1999年 | 289篇 |
1998年 | 236篇 |
1997年 | 214篇 |
1996年 | 166篇 |
1995年 | 166篇 |
1994年 | 168篇 |
1993年 | 138篇 |
1992年 | 120篇 |
1991年 | 110篇 |
1990年 | 101篇 |
1989年 | 67篇 |
1988年 | 67篇 |
1987年 | 65篇 |
1986年 | 57篇 |
1985年 | 78篇 |
1984年 | 56篇 |
1983年 | 57篇 |
1982年 | 46篇 |
1981年 | 39篇 |
1980年 | 24篇 |
1979年 | 28篇 |
1978年 | 17篇 |
1977年 | 13篇 |
1976年 | 18篇 |
1975年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 255 毫秒
21.
22.
23.
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
24.
25.
《中国现代医生》2019,57(33):60-62
目的分析低分子肝素治疗D-二聚体升高支原体肺炎的有效性。方法选取我院2018年1~12月收治的64例D-二聚体升高支原体肺炎患儿作为研究对象,按照数字盲选法将其均分为两组(n=32),对照组采用常规治疗,观察组在常规治疗基础上给予低分子肝素,对比两组治疗效果。结果治疗后,观察组的血小板(PLT)、D-二聚体水平明显低于对照组(P0.05);观察组的发热时间、住院时间均短于对照组(P0.05);观察组治疗总有效率明显高于对照组(P0.05)。结论将低分子肝素应用于D-二聚体升高支原体肺炎患儿的治疗中,可有效改善患儿体内的凝血系统功能,缩短病情恢复时间,提高治疗效果,促进其病情恢复。 相似文献
26.
Shafqat R. Chaudhry Ilana S. Lendvai Sajjad Muhammad Philipp Westhofen Johannes Kruppenbacher Lukas Scheef Henning Boecker Dirk Scheele Rene Hurlemann Thomas M. Kinfe 《Brain stimulation》2019,12(3):643-651
Objective
To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs.Methods
This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency [headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state [sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers [inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls.Results
No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome [sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1β was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up [p?<?0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-α (TNF-α), leptin, adiponectin, ghrelin remained unchanged [p?>?0.05]. No severe device-/stimulation-related adverse events occurred.Conclusion
2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1β plasma levels [inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- [IL-6, HMGB-1, TNF-α, leptin] and anti-inflammatory [IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations [omics]. 相似文献27.
Merkel cell carcinoma (MCC) is a rare neuroendocrine carcinoma of the skin, for which the exact mechanisms of carcinogenesis remain unknown. Therapeutic options for this highly aggressive malignancy have historically been limited in both their initial response and response durability. Recent improvements in our understanding of MCC tumor biology have expanded therapeutic options for these patients, namely through the use of immunotherapies such as immune checkpoint inhibitors. Further elucidation of the tumor mutational landscape has identified molecular targets for therapies, which have demonstrated success in other cancer types. In this review, we discuss both current and investigational immune and molecular targets of therapy for MCC. 相似文献
28.
Precision Medicine is becoming the new paradigm in healthcare as it enables better resources allocation, treatment optimization with a potential side-effects reduction and consequent impact on quality of life and survival. This revolution is being catalyzed by liquid biopsy technologies, which provide prognostic and predictive information for advanced cancer patients, without the analytical and procedural drawbacks of tissue-biopsy. In particular, circulating tumor DNA (ctDNA) is gaining momentum as a clinically feasible option capable to capture both spatial and temporal tumor heterogeneity.Several techniques are currently available for ctDNA extraction and analysis, each with its preferential case scenarios and preanalytical implications which must be taken into consideration to effectively support clinical decision-making and to better highlight its clinical utility.Aim of this review is to summarize both analytical developments and clinical evidences to offer a comprehensive update on the deployment of ctDNA in breast cancer’s (BC) characterization and treatment. 相似文献
29.
30.
Zafar Iqbal Ambreen Iqbal Zaman Ashraf Muhammad Latif Mubashir Hassan Humaira Nadeem 《Drug development research》2019,80(5):646-654
A series of N-(5-(alkylthio)-1,3,4-oxadiazol-2-yl)methyl)benzamides 6a–i were synthesized as alkaline phosphatase inhibitors. The intermediate 5-substituted 1,3,4-oxadiazole-2-thione 4 was synthesized starting with hippuric acid. Hippuric acid in the first step was converted into corresponding methyl ester 2 which upon reaction with hydrazine hydrate furnished the formation of hydrazide 3 . The hippuric acid hydrazide was then cyclized into 5-substituted 1,3,4-oxadiazole-2-thione 4 . The intermediate 4 was then reacted with alkyl or aryl halides 5a–5i to afford the title compounds N-(5-(methylthio)-1,3,4-oxadiazol-2-yl)methyl)benzamides 6a–i . The bioassay results showed that compounds 6a–i exhibited good to excellent alkaline phosphatase inhibitory activity. The most potent activity was exhibited by the compound 6i having IC50 value 0.420 μM, whereas IC50 value of standard (KH2PO4) was 2.80 μM. Molecular docking studies was performed against alkaline phosphatase enzyme (PDBID 1EW2) to check binding affinity of the synthesized compounds 6a–i against target protein. The docking results showed that three compounds 6c , 6e , and 6i have maximum binding interactions with binding energy values of −8 kcal/mol. The compound 6i displayed the interactions of oxadiazole ring nitrogen with amino acid His265 having a binding distance 2.13 Ǻ. It was concluded from our results that synthesized compounds, especially compound 6i may serve as lead structure to design more potent inhibitors of human alkaline phosphatase. 相似文献